Computational evidence for the ligand selectivity to the α4β2 and α3β4 nicotinic acetylcholine receptors

Bioorganic and Medicinal Chemistry

Volumn 14, Issue 23, 2006, Pages 7936-7942

  Yuan, Hongbin ^a   Petukhov, Pavel A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Docking; Nicotinic acetylcholine receptor; Non conserved amino acid; Selectivity

Indexed keywords

A 84543; EPIBATIDINE; NICOTINIC RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; LIGAND BINDING; MOLECULAR DYNAMICS; MOLECULAR MODEL; NONHUMAN; PROTON TRANSPORT; RAT;

BINDING SITES; HUMANS; LIGANDS; MODELS, MOLECULAR; PROTEIN BINDING; RECEPTORS, NICOTINIC; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33750037977     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2006.07.049     Document Type: Article

References (33)

1. Karlin A. Nat. Rev. Neurosci. 3 (2002) 102-114
2. Lester H.A., Dibas M.I., Dahan D.S., Leite J.F., and Dougherty D.A. Trends Neurosci. 27 (2004) 329-336
3. Lindstrom J. Mol. Neurobiol. 15 (1997) 193-222
4. Paterson D., and Nordberg A. Prog. Neurobiol. 61 (2000) 75-111
5. Lloyd G.K., and Williams M. J. Pharmacol. Exp. Ther. 292 (2000) 461-467
6. Sine S.M. J. Neurobiol. 53 (2002) 431-446
7. Beers W.H., and Reich E. Nature 228 (1970) 917-922
8. Sheridan R.P., Nilakantan R., Dixon J.S., and Venkataraghavan R. J. Med. Chem. 29 (1986) 899-906
9. Barlow R.B., and Johnson O. Br. J. Pharmacol. 98 (1989) 799-808
10. Barreiro E.J., Barreiro G., Guimaraes C.R.W., and de Alencastro R.B. J. Mol. Struct.-THEOCHEM 532 (2000) 11-22
11. Tonder J.E., Olesen P.H., Hansen J.B., Begtrup M., and Pettersson I. J. Comput. Aided. Mol. Des. 15 (2001) 247-258
12. Wei Z.L., Petukhov P.A., Xiao Y., Tuckmantel W., George C., Kellar K.J., and Kozikowski A.P. J. Med. Chem. 46 (2003) 921-924
13. Brejc K., van Dijk W.J., Klaassen R.V., Schuurmans M., van Der Oost J., Smit A.B., and Sixma T.K. Nature 411 (2001) 269-276
14. Celie P.H., van Rossum-Fikkert S.E., van Dijk W.J., Brejc K., Smit A.B., and Sixma T.K. Neuron 41 (2004) 907-914
15. Le Novere N., Grutter T., and Changeux J.P. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 3210-3215
16. Sine S.M., Wang H.L., and Bren N. J. Biol. Chem. 277 (2002) 29210-29223
17. Schapira M., Abagyan R., and Totrov M. BMC Struct. Biol. 2 (2002) 1
18. Costa V., Nistri A., Cavalli A., and Carloni P. Br. J. Pharmacol. 140 (2003) 921-931
19. Wei Z.L., Xiao Y., Yuan H., Baydyuk M., Petukhov P.A., Musachio J.L., Kellar K.J., and Kozikowski A.P. J. Med. Chem. 48 (2005) 1721-1724
20. Corringer P.J., Le Novere N., and Changeux J.P. Annu. Rev. Pharmacol. Toxicol. 40 (2000) 431-458
21. Figl A., Cohen B.N., Quick M.W., Davidson N., and Lester H.A. FEBS Lett. 308 (1992) 245-248
22. Zhong W., Gallivan J.P., Zhang Y., Li L., Lester H.A., and Dougherty D.A. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 12088-12093
23. Li L., Zhong W., Zacharias N., Gibbs C., Lester H.A., and Dougherty D.A. Chem. Biol. 8 (2001) 47-58
24. Beene D.L., Brandt G.S., Zhong W., Zacharias N.M., Lester H.A., and Dougherty D.A. Biochemistry 41 (2002) 10262-10269
25. Xiao Y., Meyer E.L., Thompson J.M., Surin A., Wroblewski J., and Kellar K.J. Mol. Pharmacol. 54 (1998) 322-333
26. SYBYL (Version 7.0), Tripos, Inc., 1699 South Hanley Road, St. Louis, MO 63144.
27. Clark M., Cramer R.D., and Vanopdenbosch N. J. Comput. Chem. 10 (1989) 982-1012
28. Ghose A.K., Viswanadhan V.N., and Wendoloski J.J. J. Phys. Chem. A 102 (1998) 3762-3772
29. Viswanadhan V.N., Ghose A.K., Revankar G.R., and Robins R.K. J. Chem. Inf. Comput. Sci. 29 (1989) 163-172
30. DS Modeling 1.1, Accelrys Inc., 10188 Telesis Court, Suite 100, San Diego, CA 92121.
31. Morris G.M., Goodsell D.S., Halliday R.S., Huey R., Hart W.E., Belew R.K., and Olson A.J. J. Comput. Chem. 19 (1998) 1639-1662
32. Gasteiger J., and Marsili M. Tetrahedron 36 (1980) 3219-3228
33. Cornell W.D., Cieplak P., Bayly C.I., Gould I.R., Merz K.M., Ferguson D.M., Spellmeyer D.C., Fox T., Caldwell J.W., and Kollman P.A. J. Am. Chem. Soc. 117 (1995) 5179-5197